Does Darunavir Interact with Nevirapine?
CDI records a unknown classification for Darunavir and Nevirapine. The stored summary is: 23 Atazanavir 300/100 mg ↓ 42 (↓ 52 to ↓ 29) Atazanavir 300/100 mg ↓ 28 (↓ 40 to ↓ 14) Atazanavir 300/100 mg ↓ 72 (↓ 80 to ↓ 60) Atazanavir 400/100 mg ↓ 19 (↓ 35 to ↑ 2) Atazanavir 400/100 mg ↑ 2 (↓ 15 to ↑ 24) Atazanavir 400/100 mg ↓ 59 (↓ 73 to ↓ 40) Darunavir/Ritonavir Based on between-trial comparison. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Unknown
- Darunavir Class
- Protease Inhibitor
- Nevirapine Class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- Management
- Consult your pharmacist
- Data Source
- U.S. FDA via OpenFDA
What To Tell Your Doctor or Pharmacist
If you are taking Darunavir and your doctor is considering prescribing Nevirapine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Never stop or change either medication without first consulting your healthcare provider